Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Foteinos-Ioannis D. Dimtrakopoulos"'
Autor:
Foteinos-Ioannis D. Dimtrakopoulos, Petros Christopoulos, Mariam Elshiaty, Lea Daniello, Ioannis Pyrousis, Anastasia E Kottorou, Thomas Makatsoris, Haralabos Kalofonos, Angelos Koutras
Publikováno v:
Journal of Clinical Oncology. 40:e21096-e21096
e21096 Background: Ιmmune checkpoint inhibitors (ICIs) have tremendously changed the daily clinical practice on the treatment of advanced non-small cell lung cancer (aNSCLC). However, clinical useful biomarkers remain an unmet need. Recently, a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66482380fb7f5a2dffbab1d0ea8b2b05
https://doi.org/10.1200/jco.2022.40.16_suppl.e21096
https://doi.org/10.1200/jco.2022.40.16_suppl.e21096
Autor:
Athina Christopoulou, Petros Christopoulos, Sofia Agelaki, Eleni Isidora Perdikouri, Thomas Papastergiou, Angelos Koutras, Eleftherios Zervas, Haralabos P. Kalofonos, Evangelos Lianos, Georgios Oikonomopoulos, Sofia Baka, Nikolaos Tsoukalas, Thomas Makatsoris, Ilias Athanasiadis, Kostas N. Syrigos, Vasileios Megalooikonomou, Epaminondas Samantas, Giannis Mountzios, Foteinos-Ioannis D. Dimtrakopoulos, Foteini Kalofonou
Publikováno v:
Journal of Clinical Oncology. 39:e21164-e21164
e21164 Background: The treatment of advanced non-small cell lung cancer (aNSCLC) has tremendously changed during the last few years, especially, since immune checkpoint inhibitors (ICIs) were incorporated in the daily clinical practice. However, clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f77d321c1ca6b0869a4a3fd1c2241d2
https://doi.org/10.1200/jco.2021.39.15_suppl.e21164
https://doi.org/10.1200/jco.2021.39.15_suppl.e21164